Quick Answer
CANNAPHARMARX, INC. reported Net Income of -$11.13 million for fiscal year 2025.
CANNAPHARMARX, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.13M | -12.4% |
| 2024 | -$9.91M | -368.6% |
| 2023 | $3.69M | +143.2% |
| 2022 | -$8.53M | +3.4% |
| 2021 | -$8.83M | +55.6% |
| 2020 | -$19.89M | +2.7% |
| 2019 | -$20.45M | -560.9% |
| 2018 | -$3.09M | -46550.2% |
| 2017 | -$6.6K | +99.3% |
| 2016 | -$1.00M | +91.5% |
| 2015 | -$11.74M | -195.2% |
| 2014 | -$3.98M | -4114.2% |
| 2013 | -$94.4K | +3.7% |
| 2012 | -$98.1K | +1.6% |
| 2011 | -$99.7K | -117.3% |
| 2010 | $575.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.48M | -884.3% | -4.6% |
| June 30, 2025 | -$1.41M | -126.4% | -104.7% |
| March 31, 2025 | -$690.6K | +94.1% | +81.5% |
| December 31, 2024 | -$3.74M | — | -2085.4% |
| September 30, 2024 | $188.4K | +133.4% | -96.5% |
| June 30, 2024 | $5.36M | +385.3% | +145.8% |
| March 31, 2024 | -$11.72M | -729.4% | -1975.9% |
| September 30, 2023 | -$564.4K | +57.0% | +70.0% |
- CANNAPHARMARX, INC. showed a decrease of -12.4% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, CANNAPHARMARX, INC.’s net income has declined by 2034.5% (from $575.4 thousand to -$11.13 million).
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: